Home/Pipeline/RLS-2202

RLS-2202

Acute Delirium

Phase 1Active

Key Facts

Indication

Acute Delirium

Phase

Phase 1

Status

Active

Company

About Patrys

Patrys leverages a reformulated quetiapine IV and a novel deoxymab platform to address unmet needs in delirium and oncology.

View full company profile

Therapeutic Areas

Oncology Immunology Neurology